indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
cover-story

Post-Budget Reaction: Nikkhil K Masurkar, CEO, Entod Pharmaceuticals

IMT News Desk
A new programme to promote R&D in pharma to be taken up through the centre of excellence is a welcome move by the government in this year's budget. We are delighted with the government’s initiative for encouraging sunrise sectors like Medtech. The implementation of dedicated multidisciplinary courses for medical devices to be supported by the government in institutions to ensure skilled manpower for futuristic medical tech and high-end manufacturing and research is another much-needed move by the government. We highly welcome the implementation of such measures. The government is focussing on enhancing the healthcare infrastructure of the country through these efforts. The establishment of three centres of excellence for artificial intelligence to enable 'Make AI for India' and 'Make AI work for India' is another significant step by the government to enhance India's digital prowess. However, we are a bit disappointed by no announcement on any sort of GST changes and simplified regulations. Also, we were expecting that the government would allocate separate funds for R&D, formulation and APIs. So, I hope these factors will be taken into consideration in the coming years.  

Recommended

India’s Orthopaedic and Cardiac Implant Market Set to Touch USD 5 Billion by FY28: CareEdge Ratings

Hinge Health Debuts on NYSE, Raises $437.3 Million

CureBay Secures $21 Million to Expand Rural Health Network

Pain Relief Revolution: Reinventing Chronic Care in India

Massive Turnover, Growing FDI: India’s Pharma Sector at a Crossroads

Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake

Precision Oncology Goes Local: 4baseCare’s Genomics Lab and Atlas Set to Transform Cancer Care

GlobalData Forecasts HIV Market to Exceed $32 Billion Across Seven Major Markets by 2033

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions